59
Views
8
CrossRef citations to date
0
Altmetric
Case Report

Orthotopic liver transplantation after the combined use of locoregional therapy and sorafenib for advanced hepatocellular carcinoma

, , , , , , , , , , & show all
Pages 755-759 | Published online: 21 Jun 2013

References

  • MazzaferroVRegaliaEDociRLiver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosisN Engl J Med1996334116936998594428
  • YaoFYFerrellLBassNMLiver transplantation for hepatocellular carcinoma: expansion of the tumor size limits does not adversely impact survivalHepatology20013361394140311391528
  • MazzaferroVLlovetJMMiceliRPredicting survival after liver transplantation in patients with hepatocellular carcinoma beyond the Milan criteria: a retrospective, exploratory analysisLancet Oncol2009101354319058754
  • Gordon-WeeksANSnaithAPetrinicTFriendPJBurlsASilvaMASystematic review of outcome of downstaging hepatocellular cancer before liver transplantation in patients outside the Milan criteriaBr J Surg20119891201120821618496
  • LlovetJMSchwartzMMazzaferroVResection and liver transplantation for hepatocellular carcinomaSemin Liver Dis200525218120015918147
  • TanwarSKhanSAGroverVPGwiltCSmithBBrownALiver transplantation for hepatocellular carcinomaWorld J Gastroenterol200915445511551619938188
  • VarottiGRamacciatoGErcolaniGComparison between the fifth and sixth editions of the AJCC/UICC TNM staging systems for hepatocellular carcinoma: multicentric study on 393 cirrhotic resected patientsEur J Surg Oncol200531776076715975760
  • HanKHSeongJKimJKAhnSHLeeDYChonCYPilot clinical trial of localized concurrent chemoradiation therapy for locally advanced hepatocellular carcinoma with portal vein thrombosisCancer20081135995100318615601
  • LencioniRLlovetJMModified RECIST (mRECIST) assessment for hepatocellular carcinomaSemin Liver Dis2010301526020175033
  • TrottiAColevasADSetserACTCAE v3.0: development of a comprehensive grading system for the adverse effects of cancer treatmentSemin Radiat Oncol200313317618112903007
  • KamathPSWiesnerRHMalinchocMA model to predict survival in patients with end-stage liver diseaseHepatology200133246447011172350
  • JemalABrayFCenterMMFerlayJWardEFormanDGlobal cancer statisticsCA Cancer J Clin2011612699021296855
  • HanKHKudoMYeSLAsian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in AsiaOncology201181Suppl 115816422212951
  • BruixJShermanMManagement of hepatocellular carcinomaHepatology20054251208123616250051
  • SugawaraYTamuraSMakuuchiMLiving donor liver transplantation for hepatocellular carcinoma: Tokyo University seriesDig Dis200725431031217960065
  • TakadaYItoTUedaMLiving donor liver transplantation for patients with HCC exceeding the Milan criteria: a proposal of expanded criteriaDig Dis200725429930217960063
  • TaketomiASanefujiKSoejimaYImpact of des-gamma-carboxy prothrombin and tumor size on the recurrence of hepatocellular carcinoma after living donor liver transplantationTransplantation200987453153719307789
  • YuCYOuHYHuangTLHepatocellular carcinoma downstaging in liver transplantationTransplant Proc201244241241422410030
  • ChapmanWCMajella DoyleMBStuartJEOutcomes of neoadjuvant transarterial chemoembolization to downstage hepatocellular carcinoma before liver transplantationAnn Surg2008248461762518936575
  • BharatABrownDBCrippinJSPre-liver transplantation locoregional adjuvant therapy for hepatocellular carcinoma as a strategy to improve longterm survivalJ Am Coll Surg2006203441142017000383
  • ChanKMYuMCChouHSWuTJLeeCFLeeWCSignificance of tumor necrosis for outcome of patients with hepatocellular carcinoma receiving locoregional therapy prior to liver transplantationAnn Surg Oncol20111892638264621584831
  • VagefiPAHiroseRSorafenib combined with locoregional therapy prior to liver transplantation for hepatocellular carcinoma: an update on a previous case reportJ Gastrointest Cancer201344224624722815137
  • KulikLMAtassiBvan HolsbeeckLYttrium-90 microspheres (TheraSphere) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantationJ Surg Oncol200694757258617048240
  • AndoEYamashitaFTanakaMTanikawaKA novel chemotherapy for advanced hepatocellular carcinoma with tumor thrombosis of the main trunk of the portal veinCancer19977910189018969149014
  • ParkJYAhnSHYoonYJRepetitive short-course hepatic arterial infusion chemotherapy with high-dose 5-fluorouracil and cisplatin in patients with advanced hepatocellular carcinomaCancer2007110112913717508408
  • UeshimaKKudoMTakitaMHepatic arterial infusion chemotherapy using low-dose 5-fluorouracil and cisplatin for advanced hepatocellular carcinomaOncology201078Suppl 114815320616598
  • KimHYParkJWJooJSeverity and timing of progression predict refractoriness to transarterial chemoembolization in hepatocellular carcinomaJ Gastroenterol Hepatol20122761051105622098152
  • KudoMIzumiNKokudoNManagement of hepatocellular carcinoma in Japan: Consensus-Based Clinical Practice Guidelines proposed by the Japan Society of Hepatology (JSH) 2010 updated versionDig Dis201129333936421829027
  • YangMYJeongSWKimDKTreatment of hepatocellular carcinoma with portal vein thrombosis by sorafenib combined with hepatic arterial infusion chemotherapyGut Liver20104342342720981227